HSA Concludes Risk Benefit Profile for Nimesulide to be Unfavourable

Relocation of Tobacco Regulation Unit (Centre for Drug Administration, Health Products Regulation Group) to HSA Building at 11 Outram Road

Boehringer Ingelheim’s Voluntary Withdrawal of Clobutinol (Silomat®) Syrup

New Board of the Health Sciences Authority

HSA Requests Novartis to Temporarily Withhold Sales of Tegaserod (Zelmac®, Novartis)